<DOC>
	<DOCNO>NCT01795235</DOCNO>
	<brief_summary>Glucagon use decade test growth hormone ( GH ) reserve . The pathway GH stimulate glucagon establish . Acyl ghrelin show increase GH level stimulate increase adrenergic activity . The propose study test concept fall blood glucose likely sympathetic discharge contributes increase acyl ghrelin indirectly lead increase GH cortisol .</brief_summary>
	<brief_title>Study Glucagon , Ghrelin Growth Hormone Counterregulatory Hormones</brief_title>
	<detailed_description>Glucagon give healthy adult dose 1-1.5 mg i.m . show result peak glucagon level circulation 30 min , follow increase glucose insulin level . The subsequent decline glucose , insulin glucagon follow increase cortisol GH . Ghrelin 28 amino acid peptide release fundus stomach , within oxyntic gland small intestine . It circulate two major form , acylated des-acylated ghrelin . Acylated ghrelin strong GH-releasing effect mediate via G-protein couple ghrelin receptor . The propose study test concept fall blood glucose glucagon test likely sympathetic discharge contributes increase acyl ghrelin indirectly lead increase GH cortisol .</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<criteria>1 . Healthy normal men 2 . Age 1830 yr 3 . BMI 1827 kg/m2 1 . Medication previous surgery know affect ghrelin secretion . 2 . Medications know impact body weight ( Seroquel , tricyclic antidepressant ) . 3 . Medications know impact beta adrenergic system . 4 . Coronary artery disease , congestive heart failure , peripheral vascular disease , diabetes mellitus , significant hypertension ( BP &gt; 180 systolic &gt; 100 diastolic rest ) ; renal , hepatic , pulmonary disease ; untreated hypothyroidism , untreated hyperthyroidism ; history seizure disorder ; history malignancy ( skin cancer ) , history active chronic infection ( e.g. , HIV , tuberculosis ) . 5 . Endocrine disorder , i.e. , pheochromocytoma , adrenal insufficiency 6 . Hematocrit &lt; 41 % men 7 . History daily tobacco use within past 3 month 8 . Chronic alcohol abuse history 9 . Weight stable ( 10 % weight change past 6 month ) 10 . Strenuous exercise average 60 min/day 11 . Investigational drug within past 6 week 12 . Psychiatric history especially eat disorder 13 . Transmeridian travel within 2 week prior study 14 . Known hypersensitivity betablockers 15 . Estimated Glomerular Filtration Rate 60 mL/min/1.73m2 . 16 . Known cardiac dysrhythmia , especially first degree heart block .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>men</keyword>
</DOC>